These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29952165)

  • 1. Neuroenhancement and mood enhancement – Physiological and pharmacodynamical background.
    Weiergräber M; Ehninger D; Broich K
    Med Monatsschr Pharm; 2017 Apr; 40(4):154-64. PubMed ID: 29952165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives.
    Daubner J; Arshaad MI; Henseler C; Hescheler J; Ehninger D; Broich K; Rawashdeh O; Papazoglou A; Weiergräber M
    Neural Plast; 2021; 2021():8823383. PubMed ID: 33519929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological cognitive enhancement from a perspective of misuse and addiction].
    Franke AG; Soyka M
    Fortschr Neurol Psychiatr; 2015 Feb; 83(2):83-90. PubMed ID: 25723772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroenhancement: status quo and perspectives.
    Normann C; Berger M
    Eur Arch Psychiatry Clin Neurosci; 2008 Nov; 258 Suppl 5():110-4. PubMed ID: 18985306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological neuroenhancement and brain doping : Chances and risks].
    Franke AG; Lieb K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):853-9. PubMed ID: 20700786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroenhancement in healthy subject? A French case study].
    Micoulaud-Franchi JA; Vion-Dury J; Lancon C
    Therapie; 2012; 67(3):213-21. PubMed ID: 22874487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review.
    Battleday RM; Brem AK
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1865-81. PubMed ID: 26381811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Doping for the brain].
    Iglseder B
    Z Gerontol Geriatr; 2018 Feb; 51(2):143-148. PubMed ID: 29209802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.
    Schifano F; Catalani V; Sharif S; Napoletano F; Corkery JM; Arillotta D; Fergus S; Vento A; Guirguis A
    Drugs; 2022 Apr; 82(6):633-647. PubMed ID: 35366192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory and mood during MDMA intoxication, with and without memantine pretreatment.
    de Sousa Fernandes Perna EB; Theunissen EL; Kuypers KP; Heckman P; de la Torre R; Farre M; Ramaekers JG
    Neuropharmacology; 2014 Dec; 87():198-205. PubMed ID: 24667166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Options, limits and ethics of pharmacological neuroenhancement].
    Normann C; Boldt J; Maio G; Berger M
    Nervenarzt; 2010 Jan; 81(1):66-74. PubMed ID: 19851745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students.
    Maier LJ; Haug S; Schaub MP
    Drug Alcohol Depend; 2015 Nov; 156():221-227. PubMed ID: 26455555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses.
    Schleim S; Quednow BB
    Front Pharmacol; 2018; 9():3. PubMed ID: 29403383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing concentration, mood and memory in healthy individuals: an empirical study of attitudes among general practitioners and the general population.
    Bergström LS; Lynöe N
    Scand J Public Health; 2008 Jul; 36(5):532-7. PubMed ID: 18635734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits.
    Bisagno V; González B; Urbano FJ
    Pharmacol Res; 2016 Jul; 109():108-18. PubMed ID: 26826399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land.
    Lieberman HR; Tharion WJ; Shukitt-Hale B; Speckman KL; Tulley R
    Psychopharmacology (Berl); 2002 Nov; 164(3):250-61. PubMed ID: 12424548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Case of Pharmacological Neuroenhancement: Medical, Judicial and Ethical Aspects from a German Perspective.
    Franke AG; Northoff R; Hildt E
    Pharmacopsychiatry; 2015 Nov; 48(7):256-64. PubMed ID: 26252723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hacking the Brain: Dimensions of Cognitive Enhancement.
    Dresler M; Sandberg A; Bublitz C; Ohla K; Trenado C; Mroczko-Wąsowicz A; Kühn S; Repantis D
    ACS Chem Neurosci; 2019 Mar; 10(3):1137-1148. PubMed ID: 30550256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive enhancement in children and adolescents: is it in their best interests?
    Gaucher N; Payot A; Racine E
    Acta Paediatr; 2013 Dec; 102(12):1118-24. PubMed ID: 24033708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroenhancement].
    Gründer G; Bartsch T
    Nervenarzt; 2014 Dec; 85(12):1536-43. PubMed ID: 25403289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.